The summer of 2023 saw the approval of a new treatment option for certain patients with uveal melanoma, a form of cancer that begins in the eye and remains a challenge to treat. Richard Staines ...

Uveal melanoma is the most common primary malignancy of the eye and frequently leads to metastatic death. Until the mid-20th Century, the only treatment for uveal melanoma was enucleation.

Jeff Abramowitz from Pennsylvania told Newsweek: "That whole week before the surgery involved realizations of 'lasts.'" ...

Patients with uveal melanoma face many threats: early death, pain, visual handicap, and facial disfigurement, which result in loss of income and independence, with restrictions on occupational ...

Immunocore reports third quarter financial results and provides a business updateKIMMTRAK® (tebentafusp-tebn) net revenues of $80.2 million in 3Q ...

The causes, symptoms, treatment and prevention of melanoma of the eyeMedically reviewed by Oliver Eng, MDMedically reviewed ...

IDEAYA Biosciences (IDYA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

The biotech already narrowed the focus of the selected tumor-infiltrating lymphocyte (TIL) therapy in August to colorectal cancer, head and neck cancer and uveal melanoma, deprioritizing its work ...

It is important to highlight that both IL and small choroidal melanoma are subcategories of primary uveal melanoma. Having said that, uveal melanoma occurs with the growth of malignant cells on ...